In every state across America, Medicaid programs are under serious budgetary pressure. The need to contain costs has led to various forms of restriction in the coverage for drug therapy, including ...

Retrospective analysis of medical and pharmacy claims for patients diagnosed with schizophrenia or bipolar disorder in 24 state Medicaid programs. Applying formulary restrictions to atypical ...

About a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify “might be right for them.” Few appeared to be ...

Objective: To review clinical trials and reports describing the efficacy and safety of atypical antipsychotics (olanzapine, ziprasidone, quetiapine, aripiprazole) in the treatment of autistic or other ...

Atypical antipsychotic medications, developed to treat schizophrenia and bipolar disorder, are frequently prescribed for many off-label uses. A new study finds that medical evidence suggests the drugs ...

Do you still use atypical antipsychotics as a first-line medical treatment for agitated patients with Alzheimer's disease? Has the role of atypical antipsychotics for Alzheimer's patients changed ...

Antipsychotic drugs are frequently prescribed as a treatment for the behavioral symptoms of dementia. Compared with use of atypical antipsychotics, the use of typical antipsychotics is commonly ...

A warning issued by the Food and Drug Administration regarding the use of atypical antipsychotics for the treatment of dementia was associated with a significant decline in the use of these ...

Schneider et al. (Oct. 12 issue) 1 conclude that the adverse effects of atypical antipsychotic drugs for the treatment of psychosis, aggression, and agitation in patients with Alzheimer's disease ...

Impairments in cognitive processes, such as deficits in executive function, verbal memory and attention, are prevalent in most patients with schizophrenia (Breier 1999). Some atypical antipsychotic ...

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify iwaters@healio.com if there are concerns ...

– Real-World Evidence of Positive Impact of LYBALVI® (olanzapine and samidorphan) on Treatment Patterns and Rates of Relapse Among Patients with Schizophrenia or Bipolar I Disorder, Including Young ...